High expression of CPT-1A in breast cancer patients correlates with a decreased overall survival (p = 0.007, Fig. 1a) and stage as more advanced breast cancers show higher expression of CPT-1A (p = 0.0035, Fig. 1b). Here, CPT1A is linked to breast carcinoma.